Bridgebio Pharma Inc (BBIO): Congress and insider trades
Who in Congress and inside the company traded BBIO, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Bridgebio Pharma Inc (BBIO) is a listed stock on NASDAQ.
- 1 member of Congress filed 5 buys and 0 sells of BBIO, the latest published 2026-06-09 (9 June 2026).
- Insiders filed 0 open market buys worth $0 and 16 sells worth $40M, the latest filed 2026-08-20 (20 August 2026).
- Across 3 scored buys, Congress averaged +7.4% against the S&P 500 (SPY) over the 90 days after disclosure, with 67% of them ahead of the index. That result is too few trades to draw a conclusion.
- Data as of 2026-09-29 (29 September 2026).
Congress trades in BBIO
as of 2026-06-09| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 9 Jun 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 28 | +5.1% |
| 11 May 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 9 | +23.4% |
| 8 Apr 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 20 | -6.2% |
| 8 Apr 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 19 | -6.2% |
| 8 Apr 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 35 | -6.2% |
Nothing matches that search.
Insider trades in BBIO
as of 2026-08-20| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 20 Aug 2026 | Kumar Neil | sell | 34,980 | $82.53 | $2.9M | n/a |
| 20 Aug 2026 | Kumar Neil | sell | 10,000 | $84.03 | $840K | n/a |
| 13 Jul 2026 | Cook Jennifer E. | sell | 148,589 | $88.54 | $13M | n/a |
| 13 Jul 2026 | Ellis Andrea | sell | 17,167 | $84.00 | $1.4M | n/a |
| 24 Jun 2026 | Cook Jennifer E. | sell | 2,196 | $68.57 | $151K | n/a |
| 24 Jun 2026 | Valantine Hannah | sell | 2,196 | $68.57 | $151K | n/a |
| 24 Jun 2026 | Valantine Hannah | sell | 2,808 | $68.00 | $191K | n/a |
| 24 Jun 2026 | Cook Jennifer E. | sell | 37,167 | $70.00 | $2.6M | n/a |
| 8 Jun 2026 | Kumar Neil | sell | 40,000 | $67.46 | $2.7M | n/a |
| 8 Jun 2026 | Kumar Neil | sell | 40,000 | $67.88 | $2.7M | n/a |
| 26 May 2026 | Kumar Neil | sell | 26,103 | $69.44 | $1.8M | n/a |
| 4 May 2026 | Apuli Maricel | sell | 2,000 | $71.58 | $143K | n/a |
| 13 Apr 2026 | Kumar Neil | sell | 40,000 | $74.60 | $3.0M | n/a |
| 13 Apr 2026 | Kumar Neil | sell | 40,000 | $74.62 | $3.0M | n/a |
| 16 Mar 2026 | Kumar Neil | sell | 40,000 | $68.73 | $2.7M | n/a |
| 16 Mar 2026 | Kumar Neil | sell | 40,000 | $68.80 | $2.8M | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought BBIO?
5 Congress buys by 1 member and 0 insider buys are on file. The tables on this page list every one.
Did buying BBIO after a disclosure beat the market?
Across 3 scored buys, Congress averaged +7.4% against the S&P 500 (SPY) over the 90 days after disclosure, with 67% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.